Back to Search

MARY OEFELEIN, M.D.

M.D.

Internal Medicine Physician

NPI: 1467437681IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

MD00043718(WA)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY

Class of 1990

Research & Publications (20)

Delayed presentation of urinoma after radiofrequency ablation-assisted laparoscopic partial nephrectomy.
PMID 16426128·J Endourol·2006
4-observational
Words of wisdom. Re: determining dosing intervals for LHRH agonists based on serum testosterone levels: a prospective study.
PMID 18510955·Eur Urol·2008
8-other
Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
PMID 19634167·Neurourol Urodyn·2010
4-observational
Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-64.
PMID 18963417·Eur Urol·2009
8-other
Re: Urinary retention and post-void residual urine in men: separating truth from tradition: S. A. Kaplan, A. J. Wein, D. R. Staskin, C. G. Roehrborn and W. D. Steers, J Urol 2008; 180: 47-54.
PMID 19110271·J Urol·2009
8-other
Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
PMID 18829154·Eur Urol·2009
8-other
Androgen suppression therapy and prostate cancer: balancing the harms and the benefits.
PMID 18988289·Cancer·2008
8-other
Estrogenic side effects of androgen deprivation therapy.
PMID 18231613·Rev Urol·2007
8-other
Testosterone replacement therapy after primary treatment for prostate cancer.
PMID 15643240·J Urol·2005
8-other
Prospective predictors of urinary continence after anatomical radical retropubic prostatectomy: a multivariate analysis.
PMID 14727136·World J Urol·2004
8-other
Prognostic significance of obstructive uropathy in advanced prostate cancer.
PMID 15183963·Urology·2004
8-other
Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer.
PMID 15126803·J Urol·2004
8-other
The impact of osteoporosis in men treated for prostate cancer.
PMID 15123410·Urol Clin North Am·2004
6-review
Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era.
PMID 15017212·J Urol·2004
8-other
Chronic pain syndrome after laparoscopic radical nephrectomy.
PMID 14532814·J Urol·2003
5-case
Effective testosterone suppression for patients with prostate cancer: is there a best castration?
PMID 12893320·Urology·2003
6-review
Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection.
PMID 12853816·J Urol·2003
5-case
Urologic manifestations of nonurologic diseases gastrointestinal disorders.
PMID 12580558·Urol Clin North Am·2003
6-review
Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer.
PMID 12478147·J Urol·2003
3-trial
The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?
PMID 12394692·J Urol·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
104 W 5TH AVE, SUITE 200W
SPOKANE, WA 99204

Location

Practice Location

104 W 5TH AVE, SPOKANE, WA
(509) 744-3750

Quick Facts

NPI
1467437681
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
36
Publications
20

Are you this provider?

Claim Your Profile